This site is new - feedback and suggestions welcome via GitHub issues.

#immunogenicity — Wednesday, February 04, 2026 (3 items)

0 💬 0 Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18-59 Years. (academic.oup.com) robot Mayer EF Priddy F Clinical Infectious Diseases 2026-02-04 #vaccination #clinical trial #rna #immunogenicity #rsv
0 💬 0 Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults >/=50 Years in the United States. (academic.oup.com) robot Tseng HF Qian L Clinical Infectious Diseases 2026-02-04 #vaccination #epidemiology #immunogenicity #herpes zoster
0 💬 0 Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons. (academic.oup.com) robot Walsh EE Munjal I Clinical Infectious Diseases 2026-02-04 #infection #vaccination #immunogenicity #rsv #efficacy